Surgery for Stage IV Lung Cancer: Getting Surgeons in the Game for Advanced Disease

Moderator(s)

• 

  Alexis Chidi, MD PhD MSPH (she/her/hers)

  Assistant Attending
  Memorial Sloan Kettering
  New York, New York, United States

  Disclosure(s): Astra Zeneca: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); DaVinci Intuitive Surgical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
• 

  Thomas D'Amico, MD (he/him/his)

  Chief, General Thoracic Surgery
  Department of Surgery – Duke University
  Durham, North Carolina, United States

  Disclosure(s): , Medtronic: Speaker (Ongoing); Scanlan international: Consultant (Ongoing)

Presentations:

• 10:15am - 10:23am PT

  Why Are We Operating in Stage IV Disease?
  

  Invited Speaker: Mara B. Antonoff, MD (she/her/hers) – UT MD Anderson Cancer Center
• 10:23am - 10:31am PT

  Oligo vs. Poly: Does It Matter?
  

  Invited Speaker: Gaetano Rocco, MD, FRCSEd, FACS – Memorial Sloan Kettering Cancer Center
• 10:31am - 10:39am PT

  What Operation Should You Do?
  

  Invited Speaker: Samuel S. Kim, MD – Northwestern University
• 10:39am - 10:47am PT

  Timing of Surgery in Stage IV
  

  Invited Speaker: Carl Gay, MD, PhD – MD Anderson Cancer Center
• 10:47am - 10:55am PT

  Patient Selection in Stage IV
  

  Invited Speaker: Raphael S. Werner, MD MSc – Department of Thoracic Surgery, University Hospital Zurich
• 10:55am - 11:05am PT

  Outcomes of Lung Resection for M1 Non-Small Cell Lung Cancer in Modern Clinical Practice
  

  Presenting Author: Yota Suzuki, MD – University of Pittsburgh Medical Center
• 11:05am - 11:45am PT

  Panel Discussion